Kevin P Starr - Net Worth and Insider Trading

Kevin P Starr Net Worth

The estimated net worth of Kevin P Starr is at least $1.4 Billion dollars as of 2024-11-13. Kevin P Starr is the 10% Owner of Global Blood Therapeutics Inc and owns about 8,843,448 shares of Global Blood Therapeutics Inc (GBT) stock worth over $606 Million. Kevin P Starr is the 10% Owner of Blueprint Medicines Corp and owns about 5,453,753 shares of Blueprint Medicines Corp (BPMC) stock worth over $527 Million. Kevin P Starr is also the Director, 10% Owner of MyoKardia Inc and owns about 826,001 shares of MyoKardia Inc (MYOK) stock worth over $186 Million. Besides these, Kevin P Starr also holds Agios Pharmaceuticals Inc (AGIO) , Editas Medicine Inc (EDIT) , CytomX Therapeutics Inc (CTMX) , Sage Therapeutics Inc (SAGE) , Zafgen Inc (ZFGN) , Alnylam Pharmaceuticals Inc (ALNY) . Details can be seen in Kevin P Starr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin P Starr has not made any transactions after 2018-04-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kevin P Starr

To

Kevin P Starr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin P Starr owns 24 companies in total, including Revolution Medicines Inc (RVMD) , Nurix Therapeutics Inc (NRIX) , and Relay Therapeutics Inc (RLAY) among others .

Click here to see the complete history of Kevin P Starr’s form 4 insider trades.

Insider Ownership Summary of Kevin P Starr

Ticker Comapny Transaction Date Type of Owner
RVMD Revolution Medicines Inc 2020-02-12 10 percent owner
NRIX Nurix Therapeutics Inc 2020-07-23 10 percent owner
RLAY Relay Therapeutics Inc 2020-07-15 10 percent owner
LIMIT LIMIT 2018-04-18 director & 10 percent owner
LIMIT LIMIT 2020-06-02 10 percent owner
LIMIT LIMIT 2019-07-17 10 percent owner
LIMIT LIMIT 2016-12-19 10 percent owner
LIMIT LIMIT 2017-10-04 10 percent owner
LIMIT LIMIT 2018-08-22 10 percent owner
LIMIT LIMIT 2018-06-29 10 percent owner
LIMIT LIMIT 2018-03-07 director & 10 percent owner
LIMIT LIMIT 2017-11-01 10 percent owner
LIMIT LIMIT 2017-04-12 10 percent owner
LIMIT LIMIT 2016-12-16 10 percent owner
LIMIT LIMIT 2015-11-12 director
LIMIT LIMIT 2016-12-19 10 percent owner
LIMIT LIMIT 2017-01-26 10 percent owner
LIMIT LIMIT 2016-09-06 10 percent owner
LIMIT LIMIT 2015-07-13 director & 10 percent owner
LIMIT LIMIT 2015-05-14 10 percent owner
LIMIT LIMIT 2014-05-30 director
LIMIT LIMIT 2014-02-05 10 percent owner
LIMIT LIMIT 2021-02-11 10 percent owner
LIMIT LIMIT 2014-02-05 10 percent owner

Kevin P Starr Latest Holdings Summary

Kevin P Starr currently owns a total of 9 stocks. Among these stocks, Kevin P Starr owns 8,843,448 shares of Global Blood Therapeutics Inc (GBT) as of December 16, 2016, with a value of $606 Million and a weighting of 44.21%. Kevin P Starr owns 5,453,753 shares of Blueprint Medicines Corp (BPMC) as of December 19, 2016, with a value of $527 Million and a weighting of 38.47%. Kevin P Starr also owns 826,001 shares of MyoKardia Inc (MYOK) as of January 3, 2018, with a value of $186 Million and a weighting of 13.56%. The other 6 stocks Agios Pharmaceuticals Inc (AGIO) , Editas Medicine Inc (EDIT) , CytomX Therapeutics Inc (CTMX) , Sage Therapeutics Inc (SAGE) , Zafgen Inc (ZFGN) , Alnylam Pharmaceuticals Inc (ALNY) have a combined weighting of 3.76% among all his current holdings.

Latest Holdings of Kevin P Starr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GBT Global Blood Therapeutics Inc 2016-12-16 8,843,448 68.49 605,687,754
BPMC Blueprint Medicines Corp 2016-12-19 5,453,753 96.63 526,996,152
MYOK MyoKardia Inc 2018-01-03 826,001 224.91 185,775,885
AGIO Agios Pharmaceuticals Inc 2013-07-23 545,454 59.02 32,192,695
EDIT Editas Medicine Inc 2016-09-06 3,906,176 3.07 11,991,960
CTMX CytomX Therapeutics Inc 2017-04-12 5,201,767 1.04 5,409,838
SAGE Sage Therapeutics Inc 2018-04-18 340,179 5.73 1,949,226
ZFGN Zafgen Inc 2015-09-24 30,860 0.99 30,551
ALNY Alnylam Pharmaceuticals Inc 2015-11-12 0 268.95 0

Holding Weightings of Kevin P Starr


Kevin P Starr Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 108,955 shares on December 16, 2016, which brought Kevin P Starr around $2 Million.

According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years. The most-recent trade in Blueprint Medicines Corp is the sale of 106,489 shares on December 19, 2016, which brought Kevin P Starr around $3 Million.

According to the SEC Form 4 filings, Kevin P Starr has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 816,326 shares on January 3, 2018, which brought Kevin P Starr around $34 Million.

More details on Kevin P Starr's insider transactions can be found in the Insider Trading History of Kevin P Starr table.

Insider Trading History of Kevin P Starr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin P Starr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevin P Starr Ownership Network

Ownership Network List of Kevin P Starr

No Data

Ownership Network Relation of Kevin P Starr

Insider Network Chart

Kevin P Starr Owned Company Details

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Kevin P Starr is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , director & See Remarks Mark A Goldsmith , and See Remarks Stephen Michael Kelsey .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Kevin P Starr made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 34,044 shares made by Jeff Cislini , a net sale of 186,391 shares made by Stephen Michael Kelsey , and a net sale of 265,672 shares made by Mark A Goldsmith .

In summary, during the past 3 months, insiders sold 249,942 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 249,942 shares. During the past 18 months, 718,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 718,995 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Revolution Medicines Inc Insider Transactions

No Available Data

Kevin P Starr Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin P Starr. You might contact Kevin P Starr via mailing address: 29 Newbury Street, 3rd Floor, Boston Ma 02116.